TAP EN Article Feed https://ascopost.com/ All the latest and greatest ASCO Post articles and news. Fri, 30 Oct 2026 07:17:02 +00:00 en-US hourly 1 OptiTROP-Lung06: A Potential Alternative to Chemotherapy in Advanced PD-L1–Negative NSCLC? https://ascopost.com/news/october-2026/optitrop-lung06-a-potential-alternative-to-chemotherapy-in-advanced-pd-l1-negative-nsclc/ Fri, 30 Oct 2026 07:17:02 +00:00 The ASCO Post In OptiTROP-Lung06, investigators evaluated first-line sacituzumab tirumotecan plus pembrolizumab vs chemotherapy plus pembrolizumab in patients with advanced PD-L1–negative nonsquamous non-small cell lung cancer (NSCLC) without targetable genomic alterations.

]]>